2023
DOI: 10.1200/cci.22.00182
|View full text |Cite
|
Sign up to set email alerts
|

Developing a Data and Analytics Platform to Enable a Breast Cancer Learning Health System at a Regional Cancer Center

Abstract: PURPOSE This study documents the creation of automated, longitudinal, and prospective data and analytics platform for breast cancer at a regional cancer center. This platform combines principles of data warehousing with natural language processing (NLP) to provide the integrated, timely, meaningful, high-quality, and actionable data required to establish a learning health system. METHODS Data from six hospital information systems and one external data source were integrated on a nightly basis by automated extr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 42 publications
1
2
0
Order By: Relevance
“…Further, the median (95% CI) for TTNT1 was 42.3 (41.2, NA) months for patients receiving a CDK4/6i in 1L, which is longer than the median rwPFS for palbociclib combination treatment from the US DeMichele et al ( 2022) study (20.0 months [95% CI, 17.5-21.9]) for 1L [11]. Additionally, the validation metrics for AI-extracted data are consistent with the previous validations of DARWEN TM , which has been evaluated against a manual abstraction for the same clinical features in breast cancer [25], lung cancer [18,[30][31][32][33][34], ambulatory care diseases [23], and dermatology [28] at multiple Canadian institutions.…”
Section: Discussionsupporting
confidence: 66%
See 1 more Smart Citation
“…Further, the median (95% CI) for TTNT1 was 42.3 (41.2, NA) months for patients receiving a CDK4/6i in 1L, which is longer than the median rwPFS for palbociclib combination treatment from the US DeMichele et al ( 2022) study (20.0 months [95% CI, 17.5-21.9]) for 1L [11]. Additionally, the validation metrics for AI-extracted data are consistent with the previous validations of DARWEN TM , which has been evaluated against a manual abstraction for the same clinical features in breast cancer [25], lung cancer [18,[30][31][32][33][34], ambulatory care diseases [23], and dermatology [28] at multiple Canadian institutions.…”
Section: Discussionsupporting
confidence: 66%
“…Additionally, AI tools used for the extraction of clinical text can make sense of and analyze vast amounts of unstructured clinical text from pathology reports, clinical notes, and radiology reports. These tools, such as DARWEN TM , are being used for patient and disease identification, pharmacovigilance, and the development of learning health systems [23][24][25][26][27][28]. However, many tools, such as ClinicalBERT, rely on open-source datasets, such as the MIMIC-III dataset of de-identified hospital records from intensive care units [40,41].…”
Section: Discussionmentioning
confidence: 99%
“…This was a retrospective cohort study of data elements from EHRs stored at the UHN-PMCC using AI technology. The AI engine combines large language models and an ensemble of other techniques that have previously been evaluated and validated against manual abstraction across multiple disease domains, including lung cancer [22,25], breast cancer [26], dermatology [27], and infectious diseases [28] at multiple Canadian institutions, including the UHN-PMCC.…”
Section: Methodsmentioning
confidence: 99%
“…Improved health literacy has been shown to improve trust among the public regarding health communications (Paige, Krieger and Stellefson, 2016 [33]). Hence, actions to address both digital literacy and health literacy are important parts of digital health readiness.…”
Section: Figure 27 Digital Skills Of Populations In Europementioning
confidence: 99%